Market Research Point is pleased to introduce the Global and Chinese mRNA Vaccines & Therapeutics Market Insight Report 2025–2031. This comprehensive report provides a structured and in-depth analysis
OVERVIEW
Market Research Point is pleased to present the “Global and Chinese mRNA Vaccines & Therapeutics Market Insight Report 2025–2031.”
This comprehensive report provides a systematic and detailed assessment of the mRNA Vaccines & Therapeutics industry across both global and Chinese markets, with emphasis on the following key areas:
A comprehensive review of the current market landscape and emerging trends shaping the mRNA Vaccines & Therapeutics industry across China and the global market.
An evaluation of the overall market size of the mRNA Vaccines & Therapeutics industry, supported by a detailed analysis of market share across major countries and regions.
An in-depth assessment of growth opportunities across different mRNA Vaccines & Therapeutics market segments, downstream demand trends, and the competitive landscape.
An analysis of key industry challenges and critical market issues, helping stakeholders effectively address evolving business needs.
This report combines extensive secondary research with qualitative interviews conducted with industry experts and experienced market participants, ensuring accurate, objective, and comprehensive market intelligence.
The study provides a detailed evaluation of the production, consumption, import, and export landscape of the mRNA Vaccines & Therapeutics market in China. It also profiles major domestic and international manufacturers participating in the Chinese market, presenting key performance indicators including sales volume, revenue, average pricing, gross margin, and market share.
Additionally, the report offers an in-depth analysis of the mRNA Vaccines & Therapeutics market by product segment, covering product types, pricing trends, sales performance, revenue generation, and application-specific demand. Historical market data from 2020 to 2024 is included, along with forecasts extending through 2031.
Considering the uncertainty surrounding the U.S. tariff policy scheduled for implementation in 2025, the report includes a dedicated assessment of its potential market impact. It evaluates global and regional competitive dynamics, economic relationships, supply chain restructuring, and strategic responses adopted by different countries. The report concludes with practical business recommendations and a forward-looking outlook for the mRNA Vaccines & Therapeutics market.
Leading Global Companies in the mRNA Vaccines & Therapeutics Market:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba BiotechnologyGlobal mRNA Vaccines & Therapeutics Market, by Product Type:
Infectious Disease Vaccines
Cancer VaccinesGlobal mRNA Vaccines & Therapeutics Market, by Application:
Infectious Disease
CancerGlobal mRNA Vaccines & Therapeutics Market, by Region:
North America (United States and Canada)
Europe (Germany, United Kingdom, France, Italy, and Other European Countries)
Asia-Pacific (China, Japan, South Korea, Taiwan, Southeast Asia, India, and Other Asia-Pacific Countries)
Latin America (Mexico, Brazil, and Other Latin American Countries)
Middle East & Africa (Turkey, Saudi Arabia, and Other Middle East & African Countries)
I. mRNA Vaccines & Therapeutics Market Overview:
1.1 Product Definition and Research Scope
1.2 Based on product classification, the mRNA Vaccines & Therapeutics market is primarily segmented as follows:
Global mRNA Vaccines & Therapeutics Market Growth by Product Type: 2020 vs. 2024 vs. 2031
Infectious Disease Vaccines
Cancer Vaccines
1.3 Based on application, the mRNA Vaccines & Therapeutics market is mainly divided into the following segments:
Global mRNA Vaccines & Therapeutics Market Growth by Application: 2020 vs. 2024 vs. 2031
Infectious Disease
Cancer
1.4 Global mRNA Vaccines & Therapeutics Market Development Status and Future Outlook (2020-2031)
Global mRNA Vaccines & Therapeutics Market Revenue and Growth Analysis (2020-2031)
Global mRNA Vaccines & Therapeutics Market Sales Volume and Growth Trend (2020-2031)
II. Analysis of Major Global mRNA Vaccines & Therapeutics Manufacturers:
2.1 Global Sales and Market Share of Leading mRNA Vaccines & Therapeutics Manufacturers
Global Sales of Key mRNA Vaccines & Therapeutics Manufacturers (2020-2025)
Global Sales Market Share of Major mRNA Vaccines & Therapeutics Manufacturers (2020-2025)
2.2 Global Revenue and Market Share of Leading mRNA Vaccines & Therapeutics Manufacturers
Global Revenue of Key mRNA Vaccines & Therapeutics Manufacturers (2020-2025)
Global Revenue Market Share of Major mRNA Vaccines & Therapeutics Manufacturers (2020-2025)
Global Revenue Ranking of Key mRNA Vaccines & Therapeutics Manufacturers in 2024
2.3 Global Pricing Analysis of Key mRNA Vaccines & Therapeutics Manufacturers (2020-2025)
2.4 Headquarters and Geographic Distribution of Major Global mRNA Vaccines & Therapeutics Manufacturers
2.5 Establishment Year and Commercial Launch Timeline of Leading mRNA Vaccines & Therapeutics Manufacturers
2.6 Product Portfolio and Application Coverage of Major Global mRNA Vaccines & Therapeutics Manufacturers
2.7 mRNA Vaccines & Therapeutics Industry Concentration and Competitive Analysis
Industry Concentration Analysis of mRNA Vaccines & Therapeutics: Market Share of the Global Top Five Manufacturers in 2024
Global Market Share of Tier 1, Tier 2, and Tier 3 mRNA Vaccines & Therapeutics Manufacturers (Brands) in 2024
2.8 Recent Investments, Mergers & Acquisitions, and Strategic Market Activities
III. Profiles of the Following Key Companies:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Company Overview, Manufacturing Facilities, Headquarters, Competitors, and Market Position.
Product Specifications, Technical Parameters, and Market Applications of mRNA Vaccines & Therapeutics.
Global Sales, Revenue, Pricing, and Gross Margin of mRNA Vaccines & Therapeutics (2020-2025).
Company Profile and Core Business Operations.
Latest Corporate Developments.
IV. Analysis of Different Product Types of mRNA Vaccines & Therapeutics:
4.1 Global mRNA Vaccines & Therapeutics Sales by Product Type (2020-2031)
Global Sales and Market Share of mRNA Vaccines & Therapeutics by Product Type (2020-2025)
Global Sales Forecast of mRNA Vaccines & Therapeutics by Product Type (2026-2031)
4.2 Global mRNA Vaccines & Therapeutics Market Size by Product Type (2020-2031)
Global Market Size and Market Share of mRNA Vaccines & Therapeutics by Product Type (2020-2025)
Global Market Size Forecast of mRNA Vaccines & Therapeutics by Product Type (2026-2031)
4.3 Global Price Trend of mRNA Vaccines & Therapeutics by Product Type (2020-2031)
V. Analysis of mRNA Vaccines & Therapeutics by Application:
5.1 Global Sales of mRNA Vaccines & Therapeutics by Application (2020-2031)
Global Sales and Market Share of mRNA Vaccines & Therapeutics by Application (2020-2025)
Global Sales Forecast of mRNA Vaccines & Therapeutics by Application (2026-2031)
5.2 Global Market Size and Market Share of mRNA Vaccines & Therapeutics by Application (2020-2025)
Global Market Size Forecast of mRNA Vaccines & Therapeutics by Application (2026-2031)
5.3 Global Price Trend of mRNA Vaccines & Therapeutics by Application (2020-2031)
VI. Industry Development Environment Analysis
6.1 mRNA Vaccines & Therapeutics Industry Development Analysis – Market Trends
6.2 mRNA Vaccines & Therapeutics Industry Development Analysis – Entry Barriers
6.3 mRNA Vaccines & Therapeutics Industry Development Analysis – Growth Drivers
6.4 mRNA Vaccines & Therapeutics Industry Development Analysis – Market Restraints
6.5 SWOT Analysis of Global mRNA Vaccines & Therapeutics Companies
6.6 mRNA Vaccines & Therapeutics Industry Development Analysis – Regulatory Policies
Industry Regulatory Authorities and Compliance Framework
Industry Policy Development Trends
Industry Planning and Strategic Initiatives
Table of Contents
Table: Growth Trends of the mRNA Vaccines & Therapeutics Market by Product Type
Table: Growth Trends Across Different Application Segments
Table: Current Status of the mRNA Vaccines & Therapeutics Industry
Table: Future Development Trends of the mRNA Vaccines & Therapeutics Market
Table: mRNA Vaccines & Therapeutics Production Across Major Global Regions
Table: Production Market Share of mRNA Vaccines & Therapeutics in Key Global Regions
Table: Production Capacity of Major Global mRNA Vaccines & Therapeutics Manufacturers
Table: Global Leading Manufacturers – mRNA Vaccines & Therapeutics Sales, Market Share, and Revenue
Table: Global Leading Manufacturers – Revenue, Revenue Share, and Pricing of mRNA Vaccines & Therapeutics
Table: Global Revenue Ranking of Key mRNA Vaccines & Therapeutics Manufacturers in 2025
Table: China Market Leading Manufacturers – mRNA Vaccines & Therapeutics Sales, Market Share, and Revenue
Table: China Market Key Manufacturers – Revenue Share and Product Pricing
Table: Revenue Ranking of China’s Leading mRNA Vaccines & Therapeutics Manufacturers in 2025
Table: Production Distribution and Commercial Launch Timeline of Global Leading mRNA Vaccines & Therapeutics Manufacturers
Table: Product Portfolio of Major Global mRNA Vaccines & Therapeutics Manufacturers
Table: Market Position of Global Key mRNA Vaccines & Therapeutics Manufacturers in 2025 (Tier 1, Tier 2, and Tier 3)
Table: Global mRNA Vaccines & Therapeutics Market Analysis of Investments, Mergers & Acquisitions, and Other Strategic Activities
Table: mRNA Vaccines & Therapeutics Revenue Across Key Global Regions
Table: Revenue Share of Major Regions in the Global mRNA Vaccines & Therapeutics Market
Table: Regional Revenue Distribution of the Global mRNA Vaccines & Therapeutics Market
Table: mRNA Vaccines & Therapeutics Sales Volume Across Major Global Regions
Table: Regional Sales Market Share of the Global mRNA Vaccines & Therapeutics Market
Table: Regional Sales Distribution of the Global mRNA Vaccines & Therapeutics Market
Table: Profiles of the Following Companies:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
mRNA Vaccines & Therapeutics Manufacturing Facilities, Sales Coverage, Competitors, and Market Position
mRNA Vaccines & Therapeutics Product Specifications, Technical Parameters, and Market Applications
mRNA Vaccines & Therapeutics Sales, Revenue, Pricing, and Gross Margin
Company Overview and Primary Business Operations
Latest Corporate Updates
Table: Global mRNA Vaccines & Therapeutics Sales by Product Type
Table: Global Sales Market Share of mRNA Vaccines & Therapeutics by Product Type
Table: Global Sales Forecast of mRNA Vaccines & Therapeutics by Product Type
Table: Global Sales Market Share Forecast by Product Type
Table: Global Revenue of mRNA Vaccines & Therapeutics by Product Type
Table: Global Revenue Market Share of mRNA Vaccines & Therapeutics by Product Type
Table: Global Revenue Forecast of mRNA Vaccines & Therapeutics by Product Type
Table: Global Revenue Market Share Forecast by Product Type
Table: Global Price Trend of mRNA Vaccines & Therapeutics by Product Type
Table: Global Sales of mRNA Vaccines & Therapeutics by Application
Table: Global Sales Market Share of mRNA Vaccines & Therapeutics by Application
Table: Global Sales Forecast of mRNA Vaccines & Therapeutics by Application
Table: Global Sales Market Share Forecast of mRNA Vaccines & Therapeutics by Application
Table: Global Revenue of mRNA Vaccines & Therapeutics by Application
Table: Global Revenue Market Share of mRNA Vaccines & Therapeutics by Application
Table: Global Revenue Forecast of mRNA Vaccines & Therapeutics by Application
Table: Global Revenue Market Share Forecast of mRNA Vaccines & Therapeutics by Application
Table: Global Price Trend of mRNA Vaccines & Therapeutics by Application
Table: List of Upstream Raw Material Suppliers for the mRNA Vaccines & Therapeutics Industry and Contact Information
Table: List of Representative Customers of the mRNA Vaccines & Therapeutics Market
Table: Primary Sales Models and Distribution Channels of the mRNA Vaccines & Therapeutics Industry
Table: Growth Opportunities and Key Market Drivers of the mRNA Vaccines & Therapeutics Industry
Table: Major Risks Influencing the Development of the mRNA Vaccines & Therapeutics Industry
Table: Regulatory Policy Analysis for the mRNA Vaccines & Therapeutics Industry
Table: Research Scope
Table: List of Research Analysts
Chart Catalog
Figure: mRNA Vaccines & Therapeutics Product Image
Figure: Global Production Market Share of mRNA Vaccines & Therapeutics by Product Type
Figure: Global Consumption Market Share of mRNA Vaccines & Therapeutics by Application
Figure: Global mRNA Vaccines & Therapeutics Capacity, Production, Capacity Utilization, and Development Trends
Figure: Global mRNA Vaccines & Therapeutics Production, Demand, and Market Trends
Figure: Production Market Share of mRNA Vaccines & Therapeutics Across Major Global Regions
Figure: China mRNA Vaccines & Therapeutics Capacity, Production, Capacity Utilization, and Development Trends
Figure: China mRNA Vaccines & Therapeutics Production, Market Demand, and Development Trends
Figure: Global mRNA Vaccines & Therapeutics Market Sales and Growth Rate
Figure: Global mRNA Vaccines & Therapeutics Market Size
Figure: Global Market mRNA Vaccines & Therapeutics Sales and Growth Rate
Figure: Global Market Price Trend of mRNA Vaccines & Therapeutics
Figure: Global Market Share of Leading mRNA Vaccines & Therapeutics Manufacturers by Sales in 2025
Figure: Global Revenue Market Share of Key mRNA Vaccines & Therapeutics Manufacturers in 2025
Figure: China Market Share of Leading mRNA Vaccines & Therapeutics Manufacturers by Sales in 2025
Figure: China Revenue Market Share of Key mRNA Vaccines & Therapeutics Manufacturers in 2025
Figure: Global Market Share of the Top Five mRNA Vaccines & Therapeutics Manufacturers in 2025
Figure: Global Market Share of Tier 1, Tier 2, and Tier 3 mRNA Vaccines & Therapeutics Manufacturers (by Brand) in 2025
Figure: Regional Sales Revenue Market Share of the Global mRNA Vaccines & Therapeutics Market
Figure: North America mRNA Vaccines & Therapeutics Sales and Growth Rate
Figure: North America mRNA Vaccines & Therapeutics Revenue and Growth Rate
Figure: Europe mRNA Vaccines & Therapeutics Market Sales and Growth Rate
Figure: Europe mRNA Vaccines & Therapeutics Market Revenue and Growth Rate
Figure: China mRNA Vaccines & Therapeutics Sales and Growth Rate
Figure: China Market mRNA Vaccines & Therapeutics Revenue and Growth Rate
The research methodology adopted by Market Research Point follows a comprehensive and systematic process to ensure the accuracy, consistency, and reliability of the data presented in every report. Our research analysts are full-time professionals who undergo extensive training to maintain the high-quality standards established by Market Research Point. The research methodology is structured into the following five stages:
Stage 1: Secondary Research
The research process begins with extensive secondary research using trusted industry publications, trade associations, government databases, company reports, and other credible sources relevant to the target market. Our in-house research resources provide valuable background information that supports deeper market investigation. Leveraging industry expertise and analytical experience, our team carefully gathers, verifies, and organizes data from multiple reliable sources.
Stage 2: Primary Research – Industry Expert Interviews
Following secondary research, our analysts conduct comprehensive primary interviews through telephone conversations, virtual meetings, and direct interactions with industry participants. Discussions are carried out with leading manufacturers, emerging companies, suppliers, distributors, importers, wholesalers, installers, and end users to obtain first-hand market insights. Information collected during this stage is thoroughly validated against secondary research findings to ensure data accuracy and consistency.
Stage 3: Data Analysis and Validation
The research team consolidates and evaluates all information collected during the previous stages. Multiple validation techniques are applied to verify the accuracy and reliability of the findings. Whenever required, additional interviews are conducted to resolve inconsistencies and strengthen the overall quality of the research.
Stage 4: Quantitative Market Assessment
Market Research Point develops quantitative market estimates covering market size, production capacity, manufacturer performance, future market forecasts, and investment feasibility based on validated research findings. Along with numerical analysis, our experts provide comprehensive market interpretations and strategic insights, delivering proprietary intelligence that is unique to Market Research Point.
Stage 5: Quality Assurance
Before publication, every report undergoes a rigorous quality review and editorial process conducted by our experienced management and research teams. Each report is carefully examined for factual accuracy, consistency, and completeness to ensure dependable market intelligence. Continuous analyst training and strict internal quality standards enable Market Research Point to consistently deliver reliable, high-quality research reports.